Search results
Your search for process/pmg6 returned no results
Showing 961 to 975 of 2854 results for process
Showing 961 to 975 of 2854 results for process
The key stages in development of our quality standards
Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.
Triheptanoin for treating long-chain fatty acid oxidation disorders [ID3891]
Awaiting development Reference number: GID-TA11473 Expected publication date: TBC
In development Reference number: GID-IPG10405 Expected publication date: 19 November 2026
Advocacy services for adults with health and social care needs (NG227)
This guideline covers advocacy for people using health and social care services in all adult settings (including young people under 18 using adult services). It describes how to commission and deliver effective advocacy, as well as identifying who should be offered advocacy (including who is legally entitled to it). It also covers monitoring and improving advocacy services, and training and skills for advocates and practitioners.
Early value assessment (EVA) guidance on the ProKnow cloud-based system for radiotherapy data storage, communication and management.
Unintentional injuries: prevention strategies for under 15s (PH29)
This guideline covers strategies, regulation, enforcement, surveillance and workforce development in relation to preventing unintentional injuries in the home, on the road and during outdoor play and leisure.
In development Reference number: GID-TA10990 Expected publication date: TBC
In development Reference number: GID-TA11772 Expected publication date: 03 September 2026
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
In development Reference number: GID-TA11565 Expected publication date: TBC
In development Reference number: GID-TA10981 Expected publication date: TBC
In development Reference number: GID-TA11643 Expected publication date: TBC
Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.
Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.
NICE technology appraisal and highly specialised technologies guidance: the manual (PMG36)
This guide describes the methods and processes, including expected timescales, that NICE follows when carrying out health technology evaluations. The methods and processes are designed to produce robust guidance for the NHS in an open, transparent and timely way, with appropriate contribution from stakeholders. Organisations invited to contribute to health technology evaluation development should read this manual in conjunction with the NICE health technology evaluation topic selection: the manual. All documents are available on the NICE website